Trial Profile
ECT and Memantine.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 22 Jan 2013 New trial record